← Leaderboards
Vellareddy Anantharam
Pk Biosciences Corporation
$710,319
Attributed
$710,319
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $279.9K · FY2008–19$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$710,319 · 3
By mechanism
R43$710,319 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Small Business Innovation Research Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Praduman Jain · Vignet, Inc.$106,968,877
- Stephen Lev Hoffman · Sanaria, Inc.$37,771,680
- Eric Baer · Case Western Reserve University$37,136,000
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
Research focus
Small Business Innovation Research GrantDesignNeuroprotective AgentsAnimal ModelParkinson DiseaseDisease ProgressionDoseNeurodegenerative DisordersPre-ClinicalSubstantia Nigra StructureComplexPropertyLeadDopaminergic NeuronAnalogMotor SymptomMitochondriaNerve DegenerationLinkMediatingNeurochemistryFda ApprovedCell DeathFingerprint
Grant awards (4)
Preclinical evaluation of the anti-neuroinflammatory properties and pharmacokinetic profile of a novel Fyn kinase inhibitors$224,912
R43 · FY2019 · NS · contact PI
Development of Novel Metformin Analog for Treatment of Parkinson's Disease$55,000
R43 · FY2019 · NS · contact PI
Development of Novel Metformin Analog for Treatment of Parkinson's Disease$276,967
R43 · FY2018 · NS · contact PI
Development of Novel Neuroprotective Agents for Parkinson?s Disease$153,440
R43 · FY2008 · NS · contact PI